T16Ainh-A01 also inhibited the mucus secretion that was shown in the trachea of sensitized animals, suggesting that TMEM16A inhibitors may be viable in inhibiting hypersecretion in asthma (Kondo et al., 2017). This evidence concerns the gene ANO1 and asthma.